Management of the neurological manifestations of APS—what do the trials tell us?

This publication has 41 references indexed in Scilit:

• Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
  Arthritis & Rheumatism, 2002
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
  Arthritis & Rheumatism, 1999
• Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
  The American Journal of Medicine, 1996
• Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome
  Annals of Neurology, 1995
• Anticardiolipin antibodies in an unselected stroke population
  The Lancet, 1994
• Anticardiolipin antibodies are an independent risk factor for first ischemic stroke
  Neurology, 1993
• Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
  Annals of Internal Medicine, 1992
• Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.
  Stroke, 1992
• Antiphospholipid antibodies and cerebral ischemia in young people
  Neurology, 1990
• Cerebrovascular and neurologic disease associated with antiphospholipid antibodies
  Neurology, 1990